NFKB1 and prostate cancer: These data show that digitoxin suppresses signaling by both TNFα/NFκB and TGFβ/TGFBR2 pathways in castration resistant prostate cancer cells, both in vitro and in vivo, and that an important consequence is significant suppression of EMT, tumor progression and tumor recurrence.